## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-06-16T10:45:48.194Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Quick Diagnosis & Treatment" developer_entity: "MobiSystems, Inc." bundle_id: "com.mobisystems.McGrawHillCMDTQuickAnswers2014" app_store_id: "792671616" category: "Medical" primary_platform: "ios" primary_monetization: "Paid" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2019-03-20" report_date: "2026-06-16" last_verified: "2026-06-16" report_version: "10.0.20" total_reviews: 297 overall_rating: 4.71 sentiment: "Excited" sentiment_score: 75 confidence: "high" confidence_score: 0.7 top_praise_theme: "Concise bulleted formatting allows medical students to identify key clinical concepts quickly during rotations" top_complaint_theme: "Search engine functionality fails to return results for common medical terms and specific conditions" top_request_theme: "Highlighting and annotation features would allow students to mark important concepts for later review" review_sample_size: 49 total_review_count: 49 analyzed_review_count: 49 data_age_days: 0 momentum_velocity: "zombie" intelligence_version: 3 nemesis: "UpToDate" competitor_count: 7 tags: ["medical", "paid", "excited sentiment", "mobile app", "app review", "app analysis", "medical", "professionals,", "residents,"] canonical_url: "https://marlvel.ai/intel-report/medical/com-mobisystems-mcgrawhillcmdtquickanswers2014" license: "CC-BY-NC 4.0" content_version: "v2" --- # Quick Diagnosis & Treatment App Audit ## TL;DR {#tldr} - **Category**: Medical · Paid - **Signal**: Rating 4.71 · Sentiment Excited - **Recent focus**: Search engine functionality fails to return results for common medical terms and specific conditions (top complaint) · Concise bulleted formatting allows medical students to identify key clinical concepts quickly during rotations (top praise) · Highlighting and annotation features would allow students to mark important concepts for later review (top request) > **TL;DR:** Quick Diagnosis & Treatment is a medical app by MobiSystems, Inc., rated 4.71/5 by 297 users, with Excited user sentiment (75/100), available on iOS. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** Quick Diagnosis & Treatment maintains Excited user sentiment (4.71/5 from 297 reviews), with users consistently praising concise bulleted formatting allows medical students to identify key clinical concepts quickly during rotations. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.71/5 (297 reviews) | | **User Mood** | Excited | | **Category** | Medical | | **Developer** | MobiSystems, Inc. | | **Pricing** | Paid | | **Platforms** | iOS | | **Confidence** | High (0.7/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** MobiSystems, Inc. - **Category:** Medical - **Target Audience:** Medical professionals, residents, and students requiring immediate, evidence-based clinical diagnosis and treatment information in hospital or office settings. - **Platforms:** iOS - **Version Audited:** 10.0.20 - **Audit Date:** 2026-06-16 - **Signal Count:** 49 reviews analyzed - **Confidence:** High (0.7/1.0) - **App Store ID (iOS):** 792671616 - **Bundle ID:** com.mobisystems.McGrawHillCMDTQuickAnswers2014 - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-06-16 ## Executive Snapshot **What it is:** Quick Diagnosis & Treatment is a medical reference application providing evidence-based clinical diagnosis and treatment summaries for professionals and students on iOS. **Why users hire it:** Users hire this app for rapid, offline access to authoritative clinical content during hospital rotations where deep-dive research is impractical. ## App DNA (Features & Intent) - **[Differentiator] Evidence-based Medical Reference:** Access to clinical findings, diagnosis, and treatment protocols derived from the CMDT annual guide * *User Intent:* Users need clear guidance to understand and adopt the product quickly. - **[Differentiator] Camera Search:** Lookup medical terms via camera viewfinder for immediate results * *User Intent:* Users want to quickly find relevant content or features. - **[Standard] Advanced Search Tools:** Includes autocomplete, keyword lookup, fuzzy filter for spelling, and wild card search * *User Intent:* Users want to quickly find relevant content or features. ## Market Position {#market-position} QMDT maintains a 4.71 rating across 297 total ratings, positioning it as a niche professional tool. The $9.99 price point targets individual practitioners who prioritize portability over the institutional-grade EHR integration of market leaders. ## Monetization Strategy - **Model:** Paid - **Tiers:** Single purchase at $9.99 - **Price:** iOS: $9.99 - **Analysis:** Paid model anchored at $9.99, targeting professionals who require offline access to authoritative medical content. ## 🟢 User Sentiment (High Confidence: 49 of 49 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.71/5 - **Platform Split:** iOS 4.7/5 (297 ratings) - **Overall Sentiment:** Excited ### Top Praises - **Concise bulleted formatting allows medical students to identify key clinical concepts quickly during rotations** ### Top Complaints (Impact Areas) - **Search engine functionality fails to return results for common medical terms and specific conditions** ### Top Requests (What Users Want) - **Highlighting and annotation features would allow students to mark important concepts for later review** ## SWOT Analysis {#swot} **Core Strengths:** - Authoritative CMDT content provides immediate clinical credibility - Camera search reduces time-to-information for on-call practitioners - Concise formatting supports rapid review during clinical rotations **Critical Frictions:** - Search engine fails to return results for common terms - Lack of symptom-based navigation limits diagnostic utility - Table formatting issues on tablets hinder readability **Growth Levers:** - Implement symptom-based navigation to capture diagnostic-phase users - Add annotation and highlighting tools to increase student retention - Develop specialty-based browsing by organ system **Market Threats:** - AMBOSS's interactive Q&A integration threatens the student-learning segment - UpToDate's EHR integration locks out standalone mobile tools - Subscription-based rivals maintain faster clinical update cadences ## Recent Changes (v2 → v3) {#recent-changes} The app introduced new search capabilities and diagnostic-focused features, but faces increased scrutiny regarding search reliability and a lack of symptom-based navigation. **Overall trend**: Mixed **Compared at**: 2026-06-16 ### High-impact changes - **[Added] Camera Search and Advanced Search Tools** (features) — Added camera-based lookup and advanced search filters (autocomplete, fuzzy filter, wild card) to the feature set. - **[Declined] Search Engine Reliability** (sentiment) — New user complaint theme emerged: search engine fails to return results for common medical terms and conditions. ### Medium-impact changes - **[Shifted] Strategic Positioning** (positioning) — Positioning shifted from a standard reference tool to a product with a 'widening gap' against symptom-based diagnostic platforms. - **[Added] Expanded SWOT Analysis** (swot) — Added specific threats (AMBOSS, UpToDate, subscription rivals) and opportunities (symptom-based navigation, annotation tools). ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Quick Diagnosis & Treatment vs UpToDate — Head to Head - **[UpToDate](https://marlvel.ai/intel-report/medical/uptodate)** by UpToDate, Inc.: UpToDate is the industry standard for evidence-based clinical decision support, commanding the largest professional user base in the medical reference space. - **Moat strength:** High — sustainable advantage over 12 months - **Key differences:** - Maintains a massive, peer-reviewed clinical content library that serves as the gold standard for hospital-based decision support. - Integrates directly into major Electronic Health Record (EHR) systems, creating a high-friction barrier for standalone mobile-only competitors. - Operates on a high-value institutional subscription model that prioritizes enterprise-wide access over individual consumer-facing app purchases. - **Where Quick Diagnosis & Treatment wins:** - ✅ Offers a more streamlined, alphabetically arranged reference format that is faster for quick, on-the-fly clinical lookups. - ✅ Provides a lower-cost, individual-purchase model that avoids the complex institutional procurement cycles required for enterprise platforms. - **Where UpToDate wins:** - ❌ Provides deep, evidence-based clinical guidance that goes far beyond the quick-reference summaries found in the target app. - ❌ Leverages a massive, continuously updated editorial board to ensure clinical content remains current with the latest medical research. - **Verdict:** The target app should position itself as a high-speed, portable 'on-call' companion rather than attempting to compete with the deep, institutional-grade clinical depth of UpToDate. ### Contenders (Strong Challengers) - **[DynaMed](https://marlvel.ai/intel-report/medical/dynamed)** by EBSCO Publishing [Moat: Medium]: DynaMed provides a high-quality, evidence-based clinical reference tool that directly competes for the same professional clinical audience. - Utilizes a rigorous, systematic literature surveillance process to ensure clinical recommendations are updated with extreme speed. - Offers a highly structured, evidence-based summary format that allows clinicians to rapidly synthesize complex medical data. - **[Medscape](https://marlvel.ai/intel-report/medical/medscape)** by WebMD [Moat: Medium]: Medscape offers a broad, multi-functional medical ecosystem that captures a massive audience through free access and integrated news. - Provides a comprehensive, free-to-access suite including drug references, medical news, and continuing medical education (CME) modules. - Maintains high user engagement through a daily news feed that keeps clinicians updated on broader healthcare industry trends. - **[Merck Manual Professional](https://marlvel.ai/intel-report/medical/merck-manual-professional)** by Merck & Co Inc [Moat: Medium]: A highly trusted, legacy medical reference that provides deep clinical content in a format optimized for professional use. - Delivers authoritative, non-commercial clinical content that is widely respected for its academic and diagnostic accuracy. - Provides a clean, ad-free user experience that contrasts sharply with the ad-supported models of broader medical portals. ### Peers (What They Do Better) - **[PEPID®](https://marlvel.ai/intel-report/medical/pepid)** by PEPID, LLC: Focuses on clinical decision support and drug interaction tools specifically for emergency and point-of-care environments. - Specializes in emergency medicine workflows with integrated symptom checkers and rapid-fire diagnostic support tools. - Provides highly specific clinical calculators and drug interaction databases tailored for high-acuity, time-sensitive medical settings. - **[Johns Hopkins Antibiotic Guide](https://marlvel.ai/intel-report/medical/com-unboundmedicine-johnshopkinspocitguides)** by Unbound Medicine, Inc.: A specialized, high-authority reference tool focusing on infectious disease management and antibiotic stewardship. - Provides hyper-specialized, expert-curated content for antibiotic selection that general medical references often lack in depth. - Optimized for rapid, point-of-care decision making in complex infectious disease scenarios requiring precise dosing and therapy. ### New Kids on the Block (What's Innovative) - **[AMBOSS Medical Knowledge](https://marlvel.ai/intel-report/medical/us-miamed-amboss-knowledge)** by AMBOSS: Rapidly growing platform that combines high-quality medical knowledge with an innovative, interactive study and reference interface. ## App Momentum (Zombie) {#momentum} - Added four colorful interface themes. - Redesigned home page visual layout. - Optimized search speed for entries. > **Cadence:** 5 total versions · 0 majors in last 6 months · 2586 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Quick Diagnosis & Treatment is a market-leading medical app that is a paid app. With a 4.71/5 rating from 297 reviews, it delivers strong user satisfaction. > **Bottom Line:** QMDT holds a strong professional niche through authoritative content, but its legacy search and navigation architecture limits its utility as a diagnostic aid, so the PM should prioritize symptom-based lookup to prevent churn to modern, interactive rivals. **Best for:** Medical professionals, residents, and students requiring immediate, evidence-based clinical diagnosis and treatment information in hospital or office settings. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] [HIGH IMPACT] Pivot navigation to symptom-based lookup because users complain they must know the diagnosis to search → increase diagnostic utility — *Sentiment analysis identifies lack of symptom-based navigation as a top friction point.* _(trade-off: deprioritize Pause the UI theme customization work — navigation utility has 3x the impact on user retention.)_ - [ ] [INVEST] [MEDIUM IMPACT] Ship annotation and highlighting tools because students request them for study review → increase daily active usage — *Top user request theme in sentiment data.* _(trade-off: deprioritize Deprioritize the camera search refinement — annotation features drive higher stickiness for the student demographic.)_ ### Feature Gaps vs Competitors - Symptom-based navigation (available in PEPID but missing here) - Interactive Q&A banks (available in AMBOSS but missing here) - EHR integration (available in UpToDate but missing here) ### Outlook: Mixed The medical reference market is shifting toward interactive, symptom-aware diagnostic support, leaving static alphabetical tools like QMDT exposed. Unless the app evolves beyond a simple digital index, it will continue to lose ground to platforms that offer integrated clinical decision support. - 🔴 Search engine failures for common terms erode professional trust, which compounds the churn risk against symptom-aware competitors. - 🟢 Recent interface updates show active maintenance, though the lack of diagnostic-workflow features limits long-term growth potential. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.71/5 | | Total Reviews | 297 | | Sentiment | Excited (75/100) | | Confidence | High | | Pricing Model | Paid | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Quick Diagnosis & Treatment** (this app) | 4.71/5 | Excited | MobiSystems, Inc. | | [Johns Hopkins Antibiotic Guide](https://marlvel.ai/intel-report/medical/com-unboundmedicine-johnshopkinspocitguides) | 4.9/5 | Mixed | Unbound Medicine, Inc. | | [AMBOSS Medical Knowledge](https://marlvel.ai/intel-report/medical/us-miamed-amboss-knowledge) | 4.9/5 | Thrilled | AMBOSS | | [UpToDate](https://marlvel.ai/intel-report/medical/uptodate) | 4.3/5 | N/A | UpToDate, Inc. | | [Medscape](https://marlvel.ai/intel-report/medical/medscape) | 3.7/5 | N/A | WebMD | | [Merck Manual Professional](https://marlvel.ai/intel-report/medical/merck-manual-professional) | 4.8/5 | N/A | Merck & Co Inc | ## Company Profile - **Developer:** MobiSystems, Inc. - **Website:** [https://www.mobisystems.com/](https://www.mobisystems.com/) - **Social:** [Facebook](https://www.facebook.com/MobiSystems) · [X/Twitter](https://twitter.com/MobiSystems) · [YouTube](https://www.youtube.com/channel/UCedxfsAtzl7B8yftwF9_ANQ) · [LinkedIn](https://www.linkedin.com/company/mobisystems) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/quick-diagnosis-treatment/id792671616?uo=2) - **Dev Site:** [Official Website](https://www.mobisystems.com/) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*Johns Hopkins Antibiotic Guide*](https://marlvel.ai/intel-report/medical/com-unboundmedicine-johnshopkinspocitguides) (Unbound Medicine, Inc.) — 4.9/5 Rating | Mixed Sentiment - [*AMBOSS Medical Knowledge*](https://marlvel.ai/intel-report/medical/us-miamed-amboss-knowledge) (AMBOSS) — 4.9/5 Rating | Excellent Sentiment - [*UpToDate*](https://marlvel.ai/intel-report/medical/uptodate) (UpToDate, Inc.) — 4.3/5 Rating | N/A Sentiment - [*Medscape*](https://marlvel.ai/intel-report/medical/medscape) (WebMD) — 3.7/5 Rating | N/A Sentiment - [*Merck Manual Professional*](https://marlvel.ai/intel-report/medical/merck-manual-professional) (Merck & Co Inc) — 4.8/5 Rating | N/A Sentiment - [*DynaMed*](https://marlvel.ai/intel-report/medical/dynamed) (EBSCO Publishing) — 4.9/5 Rating | N/A Sentiment - [*PEPID®*](https://marlvel.ai/intel-report/medical/pepid) (PEPID, LLC) — 4.7/5 Rating | N/A Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.7/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 49 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/com-mobisystems-mcgrawhillcmdtquickanswers2014) Data licensed for AI Agent attribution under CC-BY-NC 4.0.